Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of MM-398 in Combination With Ramucirumab After Platinum Failure in Gastric Cancer

NCT03739801 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03739801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03739801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of MM-398 in Combination With Ramucirumab After Platinum Failure in Gastric Cancer
Lead sponsor
University of Southern California
Phase
Phase 1/2
Overall status
Withdrawn
Start date
April 6, 2020
Completion date
April 6, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, locally advanced unresectable gastric adenocarcinoma, metastatic gastroesophageal junction adenocarcinoma, metastatic unresectable gastric adenocarcinoma, unresectable gastroesophageal junction adenocarcinoma